Sean Michael Boyle

598 total citations
23 papers, 223 citations indexed

About

Sean Michael Boyle is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sean Michael Boyle has authored 23 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Sean Michael Boyle's work include Cancer Genomics and Diagnostics (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Sean Michael Boyle is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Sean Michael Boyle collaborates with scholars based in United States, Canada and France. Sean Michael Boyle's co-authors include Anandasankar Ray, Tom Guda, Charles W. Abbott, Richard Chen, Rachel Marty Pyke, Gábor Bartha, Éric Levy, John West, M Snyder and Lee McDaniel and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sean Michael Boyle

18 papers receiving 218 citations

Peers

Countries citing papers authored by Sean Michael Boyle

Since Specialization

Citations

This map shows the geographic impact of Sean Michael Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Michael Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Michael Boyle more than expected).

Fields of papers citing papers by Sean Michael Boyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Michael Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Michael Boyle. The network helps show where Sean Michael Boyle may publish in the future.

Co-authorship network of co-authors of Sean Michael Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Michael Boyle. A scholar is included among the top collaborators of Sean Michael Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Michael Boyle. Sean Michael Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study. 2025 ·Journal of Clinical Oncology ·(unknown), Emma Titmuss, Fábio C. P. Navarro, Charles W. Abbott, (unknown), James T. Topham, (unknown), (unknown), (unknown), Howard J. Lim, Karamjit S. Gill, Sharlene Gill, Carl J. Brown, (unknown), Adam Meneghetti, Daniel J. Renouf, David F. Schaeffer, (unknown), Sean Michael Boyle, Jonathan M. Loree	0
2	Circulating tumor DNA, pathologic response after neoadjuvant therapy, and survival: First results from TBCRC 040 (the PREDICT-DNA trial). 2025 ·Journal of Clinical Oncology ·(unknown), Heather A. Parsons, Leslie Cope, Jenna VanLiere Canzoniero, (unknown), Fábio C. P. Navarro, (unknown), Sean Michael Boyle, Jesus D. Anampa, Mothaffar F. Rimawi, Angela Pennisi, Anna Maria Storniolo, (unknown), Rita Nanda, (unknown), Gaorav P. Gupta, Erica Stringer-Reasor, Vered Stearns, Antonio C. Wolff, Ben Ho Park	4
3	Ultrasensitive circulating tumor DNA (ctDNA) detection for prognostication in triple-negative breast cancer (TNBC) post-neoadjuvant chemotherapy (NAC). 2025 ·Journal of Clinical Oncology ·Luc Cabel, (unknown), Kathleen C. Keough, Charles W. Abbott, Nicolas Pouget, Jean‐Yves Pierga, (unknown), (unknown), (unknown), Enora Laas, Lauren Darrigues, (unknown), Virginie Fourchotte, (unknown), Anne Vincent‐Salomon, Sean Michael Boyle, Richard Chen, Christophe Le Tourneau, François‐Clément Bidard	0
4	Prognostic and predictive value of ultrasensitive ctDNA monitoring in a metastatic pan-cancer cohort treated with immune checkpoint inhibitors in the context of phase 1 clinical trials. 2024 ·Journal of Clinical Oncology ·Rodrigo A. Toledo, (unknown), Oriol Mirallas, Ana Carolina Ramos Moreno, (unknown), Guzmán Alonso, María Vieito, Irene Braña, (unknown), (unknown), José Jiménez, (unknown), Cristina Viaplana, Raquel Pérez-López, Paolo Nucíforo, Charles W. Abbott, Jason R. Pugh, (unknown), Sean Michael Boyle, Elena Garralda	2
5	Ultra-sensitive ctDNA mutation tracking to identify molecular residual disease and predict relapse in patients with early breast cancer. 2024 ·Journal of Clinical Oncology ·Isaac García-Murillas, Ros Cutts, Charles W. Abbott, Sean Michael Boyle, Jason R. Pugh, Richard Chen, (unknown), Catey Bunce, Stephen Johnston, Alistair Ring, Simon Russell, (unknown), Anthony Skene, Duncan Wheatley, Ian E. Smith, Nicholas C. Turner	8
6	Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer. 2024 ·Journal of Clinical Oncology ·Andrew B. Nixon, Fábio C. P. Navarro, Katherine I. Zhou, Charles W. Abbott, Lauren E. Howard, John C. Brady, Yingmiao Liu, Jingquan Jia, Donna Niedzwiecki, Richard Chen, John H. Strickler, Sean Michael Boyle, Hope E. Uronis	1
7	Circulating tumor DNA (ctDNA) kinetics in colorectal cancer (CRC) treated with curative intent in the VICTORI study with an ultrasensitive MRD assay. 2024 ·Journal of Clinical Oncology ·(unknown), Emma Titmuss, Fábio C. P. Navarro, Charles W. Abbott, (unknown), James T. Topham, (unknown), (unknown), (unknown), Howard J. Lim, Karamjit S. Gill, Sharlene Gill, Carl J. Brown, (unknown), Adam Meneghetti, Daniel J. Renouf, David F. Schaeffer, (unknown), Sean Michael Boyle, Jonathan M. Loree	0
8	Prevalence and dynamics of circulating tumor DNA (ctDNA) among patients (pts) with HER2+ breast cancer (BC) receiving neoadjuvant paclitaxel/trastuzumab/pertuzumab (THP) in the DAPHNe trial. 2024 ·Journal of Clinical Oncology ·Adrienne G. Waks, Paolo Tarantino, (unknown), (unknown), (unknown), (unknown), (unknown), Charles W. Abbott, Sean Michael Boyle, Richard Chen, Neelam V. Desai, Laura M. Spring, Nadine Tung, Tari A. King, Ian E. Krop, Nabihah Tayob, Elizabeth A. Mittendorf, Sara M. Tolaney, Eric P. Winer, Heather A. Parsons	1
9	Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation 2023 ·Molecular & Cellular Proteomics ·Rachel Marty Pyke, (unknown), (unknown), Charles W. Abbott, (unknown), (unknown), Jason Harris, Gábor Bartha, Sejal Desai, (unknown), John West, M Snyder, Richard Chen, Sean Michael Boyle	14
10	Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma. 2023 ·Journal of Clinical Oncology ·Christoffer Gebhardt, Laura Keller, Isabel Heidrich, (unknown), (unknown), Charles W. Abbott, Sean Michael Boyle, Jason R. Pugh, Richard Chen, Ronald Simon, Stefan W. Schneider, Klaus Pantel	1
11	Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics. 2023 ·Journal of Clinical Oncology ·Andrew B. Nixon, Lee McDaniel, Jingquan Jia, Charles W. Abbott, Lauren E. Howard, John C. Brady, Katherine I. Zhou, Donna Niedzwiecki, Richard Chen, John H. Strickler, Sean Michael Boyle, Hope E. Uronis	1
12	A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity 2022 ·Nature Communications ·Rachel Marty Pyke, Dattatreya Mellacheruvu, (unknown), Charles W. Abbott, Lee McDaniel, Devayani P. Bhave, (unknown), Éric Levy, Gábor Bartha, John West, M Snyder, Richard Chen, Sean Michael Boyle	18
13	51 A combination of antigen presentation and T-cell recognition features improves neoantigen immunogenicity predictions 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), (unknown), Rachel Marty Pyke, (unknown), (unknown), Richard Chen, Sean Michael Boyle	1
14	Association of HLA loss of heterozygosity with allele-specific neoantigen expansion in response to immunotherapy. 2021 ·Journal of Clinical Oncology ·Rachel Marty Pyke, Charles W. Abbott, (unknown), (unknown), A. Dimitrios Colevas, Éric Levy, (unknown), M Snyder, (unknown), John B. Sunwoo, Richard Chen, Sean Michael Boyle	1
15	Abstract 2227: Pan-cancer shedding patterns of tumor circulating cell free DNA 2021 ·Cancer Research ·Fábio C. P. Navarro, (unknown), Mengyao Tan, Charles W. Abbott, Josette Northcott, John Lyle, Gábor Bartha, Jason Harris, John West, Richard Chen, Sean Michael Boyle	0
16	Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 therapy in squamous cell carcinoma of the head and neck. 2020 ·Journal of Clinical Oncology ·Charles W. Abbott, (unknown), (unknown), Robin Li, Rachel Marty Pyke, Éric Levy, Rebecca D. Chernock, Mena Mansour, John B. Sunwoo, A. Dimitrios Colevas, Richard Chen, Sean Michael Boyle	1
17	Abstract 5710: Molecular profiling of anti-PD-1 treated melanoma patients reveals importance of assessing neoantigen burden and tumor escape mechanisms for clinical treatment 2018 ·Cancer Research ·Jie Wang, Sean Michael Boyle, Christina Lee, Éric Levy, (unknown), Sekwon Jang, Richard Chen	1
18	Short-term memory trace mediated by termination kinetics of olfactory receptor 2016 ·Scientific Reports ·Sean Michael Boyle, (unknown), (unknown), Anandasankar Ray	5
19	Targeting a Dual Detector of Skin and CO2 to Modify Mosquito Host Seeking 2013 ·Cell ·(unknown), (unknown), Sean Michael Boyle, Tom Guda, Anandasankar Ray	111
20	Expanding the olfactory code by in silico decoding of odor-receptor chemical space 2013 ·eLife ·Sean Michael Boyle, (unknown), Anandasankar Ray	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact